2017
1 Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers. F Chereau, Y Madec, C Sabin, N Obel, E Ruiz-Mateos, G Chrysos , S Fidler, C Lehmann, R Zangerle, L Wittkop, P Reiss, O Hamouda, V Estrada Perez, M Leal, A Mocroft, P Garcia De Olalla, Ammassari, A D'Arminio Monforte, C Mussini, F Segura, A Castagna, Cavassini, S Grabar, P Morlat, De Wit, O Lambotte, L Meyer; HIV Controllers Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCOORD.
PLoS One. 2017;12(4). Abstract
2 Is response to anti-hepatitis C virus treatment predictive of mortality in hepatitis C virus/HIV-positive patients? Hepatitis C Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.
AIDS. 2017 ;31(5):661-668. Abstract
3 Inequalities by educational level in response to combination antiretroviral treatment and survival in HIV-positive men and women in Europe. Socio-economic Inequalities and HIV Working Group for Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in Euro-Coord.
AIDS. 2017 ;31(2):253-262 Abstract
2016
1 Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen. A De Luca, P Flandre, D Dunn, M Zazzi, A Wensing, MM Santoro, HF Günthard, L Wittkop, T Kordossis, F Garcia, A Castagna, A Cozzi-Lepri, D Churchill, S De Wit, NH Brockmeyer, A Imaz, C Mussini, N Obel, CF Perno, B Roca, P Reiss, E Schülter, C Torti, A can Sighem, R Zangerle, D Descamps on behalf of CHAIN and COHERE in EuroCoord.
Journal of Antimicrobial Chemotherapy 2016. doi: 10.1093/jac/dkv465. abstract
2 Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe.
Judd,R Lodwick,A Noguera-Julian,DM Gibb,K Butler,D Costagliola,C Sabin,A van Sighem,B Ledergerber,C Torti,A Mocroft,D Podzamczer,M Dorrucci,S De Wit,N Obel,F Dabis,A Cozzi-Lepri,F Garc, NH Brockmeyer,J Warszawski,MI Gonzalez-Tome,C Mussini,G Touloumi,R Zangerle,J Ghosn,A Castagna,G atkenheuer,C Stephan, L Meyer, MA Campbell, G Chene, and A Phillips. abstract
3 Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients V Bouteloup,C Sabin,A Mocroft,L Gras,N Pantazis,V Le Moing,Ad’Arminio Monforte,M Mary-Krause,B Roca,JM Miro,M Battegay,N Brockmeyer,J Berenguer,P Morlat,N Obel,S De Wit,G Fatkenheuer,R Zangerle,J Ghosn,S Perez-Hoyos,M Campbell,M Prins,G Chene,L Meyer,M Dorrucci,C Torti, R Thiebaut. abstract
4 Changing incidence and risk factors for Kaposi sarcoma by time since starting antiretroviral therapy: Collaborative analysis of 21 European cohort studies. Julia Bohlius abstract
5 Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia. J. Bohlius abstract
2015
1 Impact of body weight on virological and immunological responses to efavirenz-containing regimens in HIV-infected, treatment-naïve adults. C Marzolini, C Sabin, F Raffi, M Siccardi, C Mussini, O Launay, D Burger, B Roca, J Fehr, S Bonora, A Mocroft, N Obel, FA Dauchy, R Zangerle, C Gogos, N Gianotti, A Ammassari, C Torti, J Ghosn, G Chêne, J Grarup, M Battegay; Efavirenz, Obesity Project Team on behalf of Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.
AIDS. 2015 Jan 14;29(2):193-200. abstract
2 Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study, 2010 to 2013. The Late Presenters Working Group for COHERE in EuroCoord.
Euro Surveillance. 2015 Nov 26;20(47). abstract
3 Mortality in migrants living with HIV in western Europe (1997-2013): a collaborative study. The Migrants Working Group on behalf of COHERE in EuroCoord.
Lancet HIV. 2015 Dec;2(12):e-540-9. abstract
4 Mortality of treated HIV-1 positive individuals according to viral subtype in Europe and Canada: collaborative cohort analysis. ART-CC, CANOC, UK CHIC, COHERE in EuroCoord.
AIDS. 2015 Nov 10. e-pub ahead of print abstract
5 Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients: COHERE in EuroCoord. Hepatitis C Working Group for COHERE in EuroCoord.
BMC Infect Dis. 2015 Nov 4;15:498. article
2014
1 Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery.
FN Engsig, R Zangerle, O Katsarou, F Dabis, P Reiss, J Gill, K Porter, C Sabin, A Riordan, G Fätkenheuer, F Gutiérrez, F Raffi, O Kirk, M Mary-Krause, C Stephan, PG de Olalla, J Guest, H Samji, A Castagna, A d'Arminio Monforte, A Skaletz-Rorowski, J Ramos, G Lapadula, C Mussini, L Force, L Meyer, F Lampe, F Boufassa, HC Bucher, S De Wit, GA Burkholder, R Teira, AC Justice, TR Sterling, H M Crane, J Gerstoft, J Grarup, M May, G Chêne, SM Ingle, J Sterne, N Obel; Antiretroviral Therapy Cohort Collaboration (ART-CC) and the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.
Clin Infect Dis. 2014 May;58(9):1312-21. abstract
2 Factors associated with short-term changes in HIV viral load and CD4+ cell count in antiretroviral-naive individuals
The Natural History Project Working Group for COHERE in EuroCoord.
AIDS. 2014 June 1;28(9):1351-1356 article
3 Delayed HIV diagnosis and initiation of antiretroviral therapy: inequalities by educational level, COHERE in EuroCoord. Socio-economic inequalities and HIV Writing Group for Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord.
AIDS, 2014. 28(15): p.2297-306. abstract
2013
1 The incidence of AIDS defining illnesses (ADIs) at a current CD4 count > 200/mm3 in the post combination antiretroviral therapy era. A Mocroft, HJ Furrer, J Miro, P Reiss, C Mussini, O Kirk et al. for COHERE in EuroCoord.
Clin Inf Dis 2013 ;57(7):1038-1047
2 Risk factors and outcomes for late presentation for HIV-positive persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). A Mocroft, JD Lundgren, M Sabin, A d'Arminio Monforte, N Brockmeyer, J Casabona, A Castagna, D Costagliola, F Dabis, S De Wit, G Fätkenheuer, H Furrer, AM Johnson, O Kirk, for the Late Presenters Working Group, on behalf of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord.
PLoS Med. 2013 10(9): e1001510. online article
3 Predictors of CD4 cell counts of HIV-1-infected persons after virologic failure to all three original antiretroviral drug classes. The Pursuing Later Treatment Option II (PLATO II) project team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Group.
J Infect Dis. 2013 Mar 1;207(5):759-67.article
4 Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery.
FN Engsig, R Zangerle, O Katsarou, F Dabis, P Reiss, J Gill, K Porter, C Sabin, A Riordan, G Fätkenheuer, F Gutiérrez, F Raffi, O Kirk, M Mary-Krause, C Stephan, PG de Olalla, J Guest, H Samji, A Castagna, A d'Arminio Monforte, A Skaletz-Rorowski, J Ramos, G Lapadula, C Mussini, L Force, L Meyer, F Lampe, F Boufassa, HC Bucher, S De Wit, GA Burkholder, R Teira, AC Justice, TR Sterling, H M Crane, J Gerstoft, J Grarup, M May, G Chêne, SM Ingle, J Sterne, N Obel; Antiretroviral Therapy Cohort Collaboration (ART-CC) and the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.
Clin Infect Dis. 2014 May;58(9):1312-21. Epub 2014 Jan 22. abstract
5 Factors associated with short-term changes in HIV viral load and CD4+ cell count in antiretroviral-naive individuals
Fumiyo Nakagawa et al.
AIDS. 2014 June 1;28(9):1351-1356 abstact
2012
1 Effect of hepatitis C treatment on CD4 cell counts and the risk of death in HIV-hepatitis C co-infected patients; COHERE collaboration. Hepatitis working group for COHERE in EuroCoord.
Antivir Ther. 2012;17(8):1541-50.
2 All-cause mortality in treated HIV-infected adults with CD4 >=500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. C Lewden, V Bouteloup, S De Wit, C Sabin, A Mocroft, JC Wasmuth, A van Sighem, O Kirk, N Obel, G Panos, J Ghosn, F Dabis, M Mary-Krause, C Leport, S Perez-Hoyos, P Sobrino-Vegas, C Stephan, A Castagna, A Antinori, A d'Arminio Monforte, C Torti, C Mussini, V Isern, A Calmy, R Teira, M Egger, J Grarup, G Chêne.
Int J Epidemiol. 2012 Apr;41(2):433-445. article
3 CD4 cell count and the risk of AIDS or death in HIV-infected adults on cART with a suppressed viral load: A longitudinal cohort study from COHERE. J Young, M Psichogiou, L Meyer, S Ayayi, S Grabar, F Raffi, P Reiss, B Gazzard, M Sharland, F Gutierrez, N Obel, O Kirk, JM Miro, H Furrer, A Castagna, S De Wit, J Muñoz, J Kjær, C Colin, J Grarup, G Chêne, H Bucher.
PLoS Med. 2012 Mar;9(3):e1001194. article
4 Calendar time trends in the incidence and prevalence of triple-class viroligic failure in antiretroviral drug experienced people with HIV in Europe. F Nakagawa for the PLATO II group for COHERE in EuroCoord.
JAIDS. 2012 Mar 1;59(3):294-9. abstract
5 Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study. D Costagliola for the PLATO II group for COHERE in EuroCoord.
Lancet Infectious Diseases. 2012 Feb; 12(2):119-27. article
2011
1 Risk of triple-class virological failure in children with HIV: a retrospective cohort study. Pursuing Later Treatment Options II (PLATO II) project team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE), H Castro, A Judd, DM Gibb, K Butler, RL Lodwick, A van Sighem, JT Ramos, J Warsawski, C Thorne, A Noguera-Julian, N Obel, D Costagliola, PA Tookey, C Colin, J Kjær, J Grarup, G Chene, A Phillips.
Lancet. 2011 May 7;377(9777):1580-7. article
2 Impact of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy - a European multi-cohort study. The EuroCoord-CHAIN joint project. L Wittkop, HF Günthard, F de Wolf, D Dunn, A Cozzi-Lepri, A de Luca, C Kucherer, N Obel, V von Wyl, B Masquelier, C Stephan, C Torti, A Antinori, F Garcia, A Judd, K Porter, R Thiébaut, H Castro (née Green), AI van Sighem, C Colin, J Kjær, JD Lundgren, R Paredes, A Pozniak, B Clotet, A Phillips, D Pillay, G Chêne.
Lancet Infectious Diseases. 2011 May;11(5):363-371. Epub 2011 Feb 25.
3 HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4+ T cell lymphocytes. J Bohlius, K Schmidlin, F Boué, G Fätkenheuer, M May, AM Caro-Murillo, A Mocroft, F Bonnet, G Clifford, V Paparizos, JM Miro, N Obel, M Prins, G Chêne, M Egger.
Blood. 2011 Jun 9;117(23):6100-8. article
2010
1 Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years. Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE), R Lodwick, D Costagliola, P Reiss, C Torti, R Teira, M Dorrucci, B Ledergerber, A Mocroft, D Podzamczer, A Cozzi-Lepri, N Obel, B Masquelier, S Staszewski, F García, S De Wit, A Castagna, A Antinori, A Judd, J Ghosn, G Touloumi, C Mussini, X Duval, J Ramos, L Meyer, J Warsawski, C Thorne, J Masip, S Pérez-Hoyos, D Pillay, A van Sighem, S Lo Caputo, H Günthard, R Paredes, A De Luca, D Paraskevis, C Fabre-Colin, J Kjaer, G Chêne, JD Lundgren, AN Phillips.
Arch Intern Med. 2010 Mar 8;170(5):410-9. article
2 Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HV infection and a CD4 cell count <200 cells/mL? The Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE).
Clinical Infectious Diseases. 2010;51(5):000-000. article
2009
1 Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy. Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study group
AIDS. 2009 Sep 24;23(15):2029-37. abstract
2 Incidence and risk factors of HIV-related non-Hodgkin lymphoma in the era of combination antiretroviral therapy: European multi-cohort study.The Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study group.
Antiviral Ther. 2009; 14(8):1065-74 article
2008
1 Response to combination antiretroviral therapy: variation by age. The Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study group. AIDS. 22(12):1463-1473, July 31, 2008. article